Scientific publisher hacked, affecting 65 papers

A publisher in the Netherlands has retracted 13 published studies and withdrawn 52 that were under consideration (but not yet published) after learning that someone illegally accessed its workflows to add fake authors and manipulate text. According to Seyyed Mohammad Miri, the founder, CEO, and managing director of Kowsar Publishing, the 13 retracted papers all included extra authors … Continue reading Scientific publisher hacked, affecting 65 papers

More questions arise over gene-editing tool

A new letter signed by 20 researchers is casting additional doubts on the validity of a potentially invaluable lab tool — and alleges the lab that produced the initial results turned them away when they tried to replicate its findings in mammalian cells. In a letter published this week in Protein & Cell, the researchers … Continue reading More questions arise over gene-editing tool

Authors retract paper lacking approval to study asthma in athletes

The authors of a 2014 study about asthma in Norwegian athletes have retracted it after realizing they hadn’t obtained proper approval from an ethical committee. The study’s first and corresponding author of the study in the British Journal of Sports Medicine — Julie Stang from the Norwegian School of Sports Sciences in Oslo — told … Continue reading Authors retract paper lacking approval to study asthma in athletes

Nature Cell Bio paper may be headed for retraction

A Nature Cell Biology paper published only a few months ago by prominent researchers in Taiwan has sparked a heated discussion on PubPeer, which now includes a comment allegedly from an author saying they have requested its retraction. Although a representative of the journal wouldn’t confirm to us that the authors had requested a retraction, … Continue reading Nature Cell Bio paper may be headed for retraction

Two Harvard-led groups pull well-cited cancer papers for duplication

Two sets of authors based largely at Harvard Medical School have each retracted a paper for duplication in the same journal. Both papers — which are more than a decade old — were pulled in The Journal of Clinical Investigation on November 1 by their respective corresponding authors. One paper’s last author told us it … Continue reading Two Harvard-led groups pull well-cited cancer papers for duplication

Weekend reads: Jail for scientific fraud?; data-sharing horrors; the lighter side of retractions

The week at Retraction Watch featured the retraction of a physics society’s press release quoting U.S. president-elect Donald Trump, and an apparent blow for clairvoyance research. Here’s what was happening elsewhere:

Family decries publication of child’s picture in open access journal

An author of a paper about a boy with a rare genetic disorder has retracted it after the patient’s family revoked permission to use his photo. The 2012 paper in the Indian Journal of Dermatology, Venereology and Leprology (IJDVL) told the tale of a 14-year old boy with Delleman syndrome, a condition that often results … Continue reading Family decries publication of child’s picture in open access journal

Weekend reads: Frustrated scientists; most brutal rejection ever?; public shaming in science

The week at Retraction Watch featured 58 retractions in one fell swoop, and a look at what you should do if you find out a paper you’ve cited has been retracted. Here’s what was happening elsewhere:

Eye researcher loses fourth paper for misconduct following Georgia, VA investigation

A biologist at the University of Georgia has lost a paper after an investigation revealed she had tampered with three images. In 2014, Azza El-Remessy notched three retractions for a series of image errors. Now, a fourth retraction notice, and an expression of concern, explain there has been an investigation into her work. The investigation — conducted by two … Continue reading Eye researcher loses fourth paper for misconduct following Georgia, VA investigation

Author pulls Diabetes paper with duplicated Western blots

A researcher has retracted a paper from Diabetes after re-using some Western blots in one of the figures from other papers. According to the retraction notice, the first and corresponding author — Eric Berglund, formerly at Vanderbilt University in Nashville, Tennessee — contacted the journal himself to report the error, for which he takes full responsibility. … Continue reading Author pulls Diabetes paper with duplicated Western blots